Centessa Pharmaceuticals (CNTA) Exchange Rate Effect (2022 - 2026)

Centessa Pharmaceuticals has reported Exchange Rate Effect over the past 4 years, most recently at $1.7 million for Q4 2025.

  • Quarterly Exchange Rate Effect fell 44.49% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$448000.0 through Dec 2025, down 136.51% year-over-year, with the annual reading at -$448000.0 for FY2025, 136.51% down from the prior year.
  • Exchange Rate Effect was $1.7 million for Q4 2025 at Centessa Pharmaceuticals, up from -$501000.0 in the prior quarter.
  • Over five years, Exchange Rate Effect peaked at $3.0 million in Q4 2024 and troughed at -$1.9 million in Q3 2024.
  • The 4-year median for Exchange Rate Effect is -$116500.0 (2024), against an average of $61000.0.
  • The largest YoY upside for Exchange Rate Effect was 701.59% in 2024 against a maximum downside of 965.45% in 2024.
  • A 4-year view of Exchange Rate Effect shows it stood at $722000.0 in 2022, then crashed by 169.81% to -$504000.0 in 2023, then soared by 701.59% to $3.0 million in 2024, then plummeted by 44.49% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Exchange Rate Effect are $1.7 million (Q4 2025), -$501000.0 (Q3 2025), and -$113000.0 (Q2 2025).